Feasibility Study is First Phase of €3.4M BioWin Award LIEGE, Belgium, Oct. 25, 2017 /PRNewswire/ — Nexeon MedSystems Inc (OTCBB: NXNN)…
Nexeon Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator
Nexeon MedSystems Goes Public, Receives Innovation Grants
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems. As Nexeon MedSystems Inc.…
Nexeon MedSystems Begins Trading as NXNN
DALLAS, Sept. 28, 2017 /PRNewswire/ — Nexeon MedSystems, Inc. (OTC:QB NXNN) announced today that it has commenced “regular way” trading on…
Nexeon MedSystems “OTCQB:NXNN” Acquires Belgian Manufacturer
Additional capacity will support Company’s current commercial product manufacturing needs LIEGE, Belgium, Sept. 6, 2017 /PRNewswire/ — Nexeon MedSystems (“Nexeon” or “the…
Nexeon Closes $4.3 Million in Private Funding Round, Has Form 10 Deemed Effective
Nexeon MedSystems Inc., a biomedical manufacturing medical devices company, has closed a round of funding to expand manufacturing capacity, laying…